To include your compound in the COVID-19 Resource Center, submit it here.

Cytokinetics raises $20.1 million

Cytokinetics Inc. (NASDAQ:CYTK) raised $20.1 million through the sale of 5.3 million common

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE